Top Clinical Laboratory Services in LATAM
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top Clinical Laboratory Services in LATAM
Clinical Laboratory Services News
Genomic Testing Solutions in Latin America: Expanding Precision across Healthcare
Thursday, August 13, 2026
Genomic testing solutions are becoming an important part of healthcare across Latin America as laboratories, hospitals and specialist clinics expand access to more precise diagnostic tools. These solutions help identify genetic variations linked to inherited conditions, cancer, reproductive health, rare diseases and treatment response. The market is developing around a need for accurate testing, faster results and stronger clinical interpretation. At the same time, providers must address uneven laboratory capacity, cost pressures, data protection, sample logistics and limited access outside major cities. Progress depends on practical systems that connect testing technology with
Laboratory Capacity Becomes a Bigger Question Than Test Availability in Latin America
Wednesday, August 12, 2026
Buying decisions around genomic testing solutions in Latin America are increasingly shaped by what happens after a sample is collected rather than by the test itself. The discussion is less about whether genomic technologies exist and more about whether laboratories can process samples consistently within existing healthcare infrastructure. That distinction is changing how hospitals, diagnostic providers and commercial laboratories evaluate testing programs. Genomic testing often involves specialized workflows that extend beyond routine diagnostics. Sample handling, sequencing, interpretation and reporting all require technical expertise that may not be distributed evenly
Buyers Put Greater Weight on Clinical Integration When Evaluating Genomic Testing Solutions
Wednesday, August 12, 2026
Interest in genomic testing is spurring a more extensive discussion about how diagnostic information fits into routine clinical decision-making throughout Latin America. Purchasing conversations increasingly move beyond laboratory performance because healthcare providers also need confidence that genomic findings can be incorporated into everyday patient care without creating uncertainty for clinicians. Generating genomic data represents only one stage of the diagnostic process. Healthcare professionals must understand how reported findings relate to the patient's condition and existing clinical information. That requirement places greater attention on reporting practices an
Long-Term Investment Decisions in Genomic Testing Reflect Different Healthcare Priorities in Latin America
Wednesday, August 12, 2026
Investment in genomic testing solutions in Latin America increasingly involves timing as much as technology. Healthcare organizations considering new diagnostic resources often have to determine how genomic testing fits within wider capital planning, particularly when laboratory expansion competes with other clinical priorities. Unlike routine diagnostic equipment, genomic testing programs may involve continuing commitments beyond the initial purchase. Laboratory preparation, workforce development and ongoing service arrangements are all able to influence the overall investment picture. Buyers evaluating these solutions may therefore consider implementation over several stages i
Choosing Insurance Brokerage for Clinical Research
Friday, June 26, 2026
Insurance is now an essential part of every clinical study. Sponsors, research institutions, and CROs work in markets where rules and insurer preferences can change quickly or slowly. A policy that appears sufficient on paper may fall short for trials involving pediatric surgery, vaccine development, new cancer treatments, or experimental therapies with unknown risks. In these situations, choosing the right broker is more important than just looking at price. Executives acquiring brokerage support should treat the decision less as a placement exercise and more as a test of whether the broker can support you through claims, unexpected delays, or regulatory reviews. The central we
Emerging Trends in Clinical Research Insurance Brokerage in Latin America
Thursday, June 18, 2026
Fremont, CA: The clinical research industry in Latin America has experienced rapid growth in recent years because of medical science developments, increased healthcare infrastructure investment and rising demand for new therapies, creating more research opportunities. The region requires specialized insurance solutions because it has become a main center for clinical trials. Clinical research insurance brokerage services operate as essential elements that help reduce the distinct complex risks that organizations face while conducting their research activities. The services provided by these organizations protect stakeholders from unexpected problems while keepin
